clotrimazole has been researched along with Astrocytoma, Grade IV in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The A172 and T98G glioblastoma cells were exposed to clotrimazole and cell growth was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium chloride colorimetric assay." | 7.70 | Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro. ( Hiura, T; Khalid, MH; Shibata, S, 1999) |
| "Clotrimazole was shown to sensitize tumor cells to radiation when the cells were irradiated for 18 h post-clotrimazole treatment." | 5.36 | Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro. ( Li, Y; Liu, H; Raisch, KP, 2010) |
| "Plerixafor (AMD3100) is a new small molecular weight inhibitor of CXCR4, FDA approved to aid in stem cell mobilization." | 5.36 | Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct. ( Kast, RE, 2010) |
| "The A172 and T98G glioblastoma cells were exposed to clotrimazole and cell growth was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium chloride colorimetric assay." | 3.70 | Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro. ( Hiura, T; Khalid, MH; Shibata, S, 1999) |
| "Clotrimazole was shown to sensitize tumor cells to radiation when the cells were irradiated for 18 h post-clotrimazole treatment." | 1.36 | Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro. ( Li, Y; Liu, H; Raisch, KP, 2010) |
| "Plerixafor (AMD3100) is a new small molecular weight inhibitor of CXCR4, FDA approved to aid in stem cell mobilization." | 1.36 | Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct. ( Kast, RE, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kast, RE | 2 |
| Burns, TC | 1 |
| Halatsch, ME | 1 |
| Zhou, K | 1 |
| Yao, YL | 1 |
| He, ZC | 1 |
| Chen, C | 1 |
| Zhang, XN | 1 |
| Yang, KD | 1 |
| Liu, YQ | 1 |
| Liu, Q | 1 |
| Fu, WJ | 1 |
| Chen, YP | 1 |
| Niu, Q | 1 |
| Ma, QH | 1 |
| Zhou, R | 1 |
| Yao, XH | 1 |
| Zhang, X | 1 |
| Cui, YH | 1 |
| Bian, XW | 1 |
| Shi, Y | 1 |
| Ping, YF | 1 |
| Liu, H | 1 |
| Li, Y | 1 |
| Raisch, KP | 1 |
| Khalid, MH | 1 |
| Shibata, S | 1 |
| Hiura, T | 1 |
5 other studies available for clotrimazole and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Short review of SEC, a potential dexamethasone-sparing regimen for glioblastoma: Spironolactone, ecallantide, clotrimazole.
Topics: Clotrimazole; Dexamethasone; Glioblastoma; Humans; Peptides; Pilot Projects; Spironolactone | 2021 |
VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Plasticity; Clotrimazole; Gene Knockdown Techniques | 2018 |
Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro.
Topics: Apoptosis; Cell Line, Tumor; Clotrimazole; Combined Modality Therapy; Dose-Response Relationship, Dr | 2010 |
Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct.
Topics: Antifungal Agents; Benzylamines; Brain Neoplasms; Clotrimazole; Cyclams; Drug Synergism; Glioblastom | 2010 |
Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Division; Cisplatin; Clotrimazole; | 1999 |